Precision Oncology for Cancer Immunotherapies in Early-Phase Clinical Trials Xavier PaliardOlivier Rixe Current Opinion Open access 08 October 2019 Pages: 631 - 637
First-Line Systemic Therapy for Metastatic Clear-Cell Renal Cell Carcinoma: Critical Appraisal of Emerging Options Vivian LooMeghan SalgiaSumanta K. Pal Review Article 08 October 2019 Pages: 639 - 645
Totality of Scientific Evidence in the Development of ABP 980, a Biosimilar to Trastuzumab Hans-Christian KolbergMarco ColleoniVladimir Hanes Review Article Open access 16 October 2019 Pages: 647 - 656
PARP Inhibition in Cancer: An Update on Clinical Development Esha SachdevRoya TabatabaiMonica M. Mita Review Article 17 October 2019 Pages: 657 - 679
Adjusting Overall Survival Estimates for Treatment Switching in Metastatic, Castration-Sensitive Prostate Cancer: Results from the LATITUDE Study Susan FeyerabendFred SaadKarim Fizazi Original Research Article Open access 21 November 2019 Pages: 681 - 688
Regorafenib-Induced Hypothyroidism as a Predictive Marker for Improved Survival in Metastatic or Unresectable Colorectal Cancer Refractory to Standard Therapies: A Prospective Single-Center Study Jwa Hoon KimSun Young KimYong Sang Hong Original Research Article 25 September 2019 Pages: 689 - 697
Addition of Bevacizumab to First-Line Palliative Chemotherapy in Patients with Metastatic Small Bowel Adenocarcinoma: A Population-Based Study Laura M. LeguéFelice N. van ErningGeert-Jan Creemers Original Research Article 17 October 2019 Pages: 699 - 705
Therapy Line and Associated Predictors of Response to PD-1/PD-L1-Inhibitor Monotherapy in Advanced Non-small-Cell Lung Cancer: A Retrospective Bi-centric Cohort Study David LangFlorian HuemerBernd Lamprecht Original Research Article Open access 25 October 2019 Pages: 707 - 717
Dynamics of Plasma EGFR T790M Mutation in Advanced NSCLC: A Multicenter Study Zhengquan YangJialu LiChunming Ding Original Research Article 06 November 2019 Pages: 719 - 728
Treatment Sequencing and Clinical Outcomes in BRAF-Positive and BRAF-Negative Unresectable and Metastatic Melanoma Patients Treated with New Systemic Therapies in Routine Practice Anna M. CzarneckaPaweł TeteryczPiotr Rutkowski Original Research Article 21 November 2019 Pages: 729 - 742
Effect of Early Adverse Events on Survival Outcomes of Patients with Metastatic Colorectal Cancer Treated with Ramucirumab Huezin H. LimAshley M. HopkinsMichael J. Sorich Short Communication 01 November 2019 Pages: 743 - 748
Subcutaneous Trastuzumab: A Review in HER2-Positive Breast Cancer Young-A HeoYahiya Y. Syed Adis Drug Evaluation 04 November 2019 Pages: 749 - 758
Atezolizumab First-Line Combination Therapy: A Review in Metastatic Nonsquamous NSCLC Sohita DhillonYahiya Y. Syed Adis Drug Evaluation 14 November 2019 Pages: 759 - 768
Correction to: Combination Treatment with an Antibody–Drug Conjugate (A1mcMMAF) Targeting the Oncofetal Glycoprotein 5T4 and Carboplatin Improves Survival in a Xenograft Model of Ovarian Cancer Y. Louise WanPuja SapraPeter L. Stern Correction Open access 03 October 2019 Pages: 769 - 769
